The fund offering uncorrelated returns with downside protection
There are not many funds that are capable of delivering decent returns regardless of the wider market, with one of…
8 years ago
Latest
Infrastrata: Clearance of 200 day line targets 1.4p
Although it may be said that Infrastrata (LON:INFA) has been something of a Cinderella stock in the recent past, it…
8 years ago
The even slower death of the stockbroker analyst – part 2
I started out on this series thinking I would ask where investors - private and institutional – will go for…
8 years ago
Populist drivel
There is still no whiff of adverse rumour surrounding Six Hundred Group (LON:SIXH). This makes it a stonking buy at…
8 years ago
Echo Energy: Imminent triangle breakout towards 0.8p
Echo Energy (LON:ECHO), formerly Independent Resources, has already been one of the micro cap stocks of the year to date.…
8 years ago
Trumponomics, Corbynitis and Post-Thatcherism
You can tell a political ideology by its tax-and-spend policies. The two far extremes of the English-speaking political world -…
8 years ago
Are valuations now dangerously stretched?
Stretched Valuations Since the beginning of the year, I have been drawing the attention of the reader to the lack…
8 years ago
Challenger Acquisitions: Above 50 day line could target 8p
Having interviewed the CEO of Challenger Acquisitions (LON:CHAL) a couple of times, and having liked the concept behind the company,…
8 years ago
Investor expectations make SSE a buy
Investor expectations can be a gift or a curse. Sometimes they allow investors to buy shares at discounted prices because…
8 years ago
Silence Therapeutics: Broadening triangle formation targets 150p
It has been a long wait for fans of Silence Therapeutics (LON:SLN) to get a decent rebound in the stock,…
8 years ago